Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease
Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease
复制标题
DOI:
10.1186/s13195-020-00587-5
复制
发表时间:
2020-03-04
影响因子:
9
通讯作者:
Rowe, Christopher C.
中科院分区:
文献类型:
--
作者:
Amadoru, Sanka;Dore, Vincent;Rowe, Christopher C.
Background The Centiloid scale was developed to standardise the results of beta-amyloid (A beta) PET. We aimed to determine the Centiloid unit (CL) thresholds for CERAD sparse and moderate-density neuritic plaques, Alzheimer's disease neuropathologic change (ADNC) score of intermediate or high probability of Alzheimer's Disease (AD), final clinicopathological diagnosis of AD, and expert visual read of a positive A beta PET scan. Methods A beta PET results in CL for 49 subjects were compared with post-mortem findings, visual read, and final clinicopathological diagnosis. The Youden Index was used to determine the optimal CL thresholds from receiver operator characteristic (ROC) curves. Results A threshold of 20.1 CL (21.3 CL when corrected for time to death, AUC 0.97) yielded highest accuracy in detecting moderate or frequent plaque density while < 10 CL was optimal for excluding neuritic plaque. The threshold for ADNC intermediate or high likelihood AD was 49.4 CL (AUC 0.98). Those cases with a final clinicopathological diagnosis of AD yielded a median CL result of 87.7 (IQR +/- 42.2) with 94% > 45 CL. Positive visual read agreed highly with results > 26 CL. Conclusions Centiloid values < 10 accurately reflected the absence of any neuritic plaque and > 20 CL indicated the presence of at least moderate plaque density, but approximately 50 CL or more best confirmed both neuropathological and clinicopathological diagnosis of Alzheimer's disease.